Biotech & Bioprocessing

Harnessing Tumor Organoids for Advanced Cancer Research
Biotech & Bioprocessing Harnessing Tumor Organoids for Advanced Cancer Research

In the quest to understand and treat cancer, researchers have faced significant obstacles with traditional models such as two-dimensional cell cultures and in vivo xenografts. These methods, while useful in their own right, often fall short in accurately replicating the complex architecture and

Revolutionizing Surgery: DIP Technology in 3D Bioprinting
Biotech & Bioprocessing Revolutionizing Surgery: DIP Technology in 3D Bioprinting

3D printing technology is paving the way for significant advancements in the medical field, particularly within plastic and reconstructive surgery. The introduction of dynamic interface printing (DIP) promises to transform tissue engineering, making it possible to create patient-specific,

How Can Boat Owners Protect Against Marine Invasive Species?
Biotech & Bioprocessing How Can Boat Owners Protect Against Marine Invasive Species?

Have You Considered the Hidden Threat Beneath Your Vessel? Every time you set sail, there may be more lurking beneath the surface than you realize. Exotic marine species, hitching a ride on boat hulls, threaten local ecosystems. These invasive creatures have the potential to disrupt marine life,

UAE to Lead Affordable CAR-T Therapy with New Biomanufacturing Hub
Biotech & Bioprocessing UAE to Lead Affordable CAR-T Therapy with New Biomanufacturing Hub

In a groundbreaking initiative, Burjeel Holdings is joining forces with Caring Cross to establish advanced biomanufacturing facilities dedicated to chimeric antigen receptor (CAR)-T cell therapies in the United Arab Emirates (UAE). This collaboration aims to revolutionize the production and

Should We Bring Back Extinct Species? Lessons From Dire Wolves
Biotech & Bioprocessing Should We Bring Back Extinct Species? Lessons From Dire Wolves

Colossal Biosciences, a leading biotechnology and genetic engineering company, has announced a groundbreaking achievement: the resurrection of the dire wolf, which went extinct about 12,500 years ago. Founded in 2025, the company is also working on bringing back the woolly mammoth and has already

How Will INCOG's $75M Expansion Impact Sterile Injectables?
Biotech & Bioprocessing How Will INCOG's $75M Expansion Impact Sterile Injectables?

INCOG, a contract development and manufacturing organization (CDMO), recently made a substantial investment to expand its capabilities in the sterile injectables sector. In February 2024, the company committed $75 million to install an Optima syringe and cartridge filling line, projected to be GMP

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later